Rochester Clinical Research, Inc. – Trademark Portfolio
Entity Type: 03
Rochester Clinical Research, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ADVANCING MEDICINE. CHANGING LIVES.. The owner is based in Rochester, NY.
500 Helendale Road
Rochester, NY 14609
Showing of trademarks Trademarks
Trademark Classifications
Rochester Clinical Research, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Rochester Clinical Research, Inc. have?
Rochester Clinical Research, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Rochester Clinical Research, Inc. file in?
Rochester Clinical Research, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are Rochester Clinical Research, Inc.'s most well-known trademarks?
Rochester Clinical Research, Inc.'s registered trademark portfolio includes well-known marks such as ADVANCING MEDICINE. CHANGING LIVES.. These are among 1 currently registered trademark in the portfolio.
What is Rochester Clinical Research, Inc.'s trademark registration success rate?
Rochester Clinical Research, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.